United States· US:72789-493_4e0451aa-af58-5f2e-e063-6294a90aa3ed
Imipramine Hydrochloride
A imipramine product containing imipramine hydrochloride, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Imipramine is registered in 11 of 19 countries.
Countries holding a registration under ATC N06AA02 (imipramine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 5 of them publish a price we can compare per daily dose
Imipramine · ATC N06AA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- IMIPRAMINE HYDROCHLORIDE
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- N06AA02
- ATC class
- Imipramine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 13, 2026
Packs & prices · 4
- ndc1172789-493-01
- ndc1172789-493-95
- ndc117278949301100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-493-01)
- ndc1172789493951000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72789-493-95)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
475 interactions on record for imipramine.
Graded by severity as the source publishes them — 64 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Imipramine · interactions on record
475 records
- 64 severe
- 252 moderate
- 16 minor
- 60 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
83 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Imipramine in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomImipramine 100mg/5ml oral solutionSpecial Order
- CanadaIMIPRAMINEAA PHARMA INC
- SpainTOFRANIL 10 mg COMPRIMIDOS RECUBIERTOSAmdipharm Limited
- BelgiumTofranil 10 mgAmdipharm
- FranceTOFRANIL 10 mg, comprimé enrobéAMDIPHARM
- NorwayImipramin-neuraxpharmNeuraxpharm Arzneimittel
- GermanyImipramin NeuraxpharmNeuraxpharm Arzneimittel Gmbh
- NetherlandsImipramine HCl CF 25 mg, omhulde tablettenCentrafarm B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Tofranil
- Cyprus · Imipramine Remedica
- Czechia · Melipramin
- Germany · Imipramin Neuraxpharm
- Denmark · Imipramin
- Spain · Tofranil
- France · Tofranil
- United Kingdom (Northern Ireland) · Imipramine, Imipramine Crescent Pharma
- Hungary · Melipramin
- Malta · Imipramine
- Netherlands · Imipramine Hcl Cf
- Portugal · Tofranil
- Slovakia · Melipramin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa1cb4e9-4d01-4424-a6ed-aed3a3d975c7 GET /v1/drugs/aa1cb4e9-4d01-4424-a6ed-aed3a3d975c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "50",
"substance": "IMIPRAMINE HYDROCHLORIDE",
"productndc": "72789-493",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA040903",
"marketing_category": "ANDA"
}See everything about imipramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.